Dr Suzanna Lindsey-Temple: Ledger

Stories naming Dr Suzanna Lindsey-Temple. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Founder	Gene-S	Dealroom, Startup News (WA) (Thu 2 Nov 2023), Startup News (WA) (Fri 21 Jan 2022)

Exit / M&A

Syngenis-backed venture Gene S Dx acquires Australian pharmacogenomics platform Rosa

A new precision-medicine company formed by Perth's Syngenis Labs, a research institute and two scientists has bought Gene S, maker of the Rosa pharmacogenomics tool; no price was disclosed.

Dealroom Wed 23 Sep 2026 Gene-S Perron Institute SynGenis Pty Ltd Dr Suzanna Lindsey-Temple Dr Svetlana Baltic Thomas Hanly

2 deals

Purpose Ventures backs local biotech startup

WA VC fund Purpose Ventures has taken on genetic testing startup Gene S as its fourth investment; earlier 2023 backing of PlanCare, Paperly and IDEAcademy is recalled, and the fund's $45m size noted.

Startup News (WA) Thu 2 Nov 2023 Purpose Ventures Gene-S IDEAcademy Paperly PlanCare Dr Suzanna Lindsey-Temple Dr Svetlana Baltic

Dr Suzanna Lindsey-Temple

Roles

Coverage

Syngenis-backed venture Gene S Dx acquires Australian pharmacogenomics platform Rosa

Purpose Ventures backs local biotech startup